Protalix BioTherapeutics, Inc. (PLX)

Typically moves ±9.05% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED

Protalix BioTherapeutics, Inc. (PLX) has reported earnings 22 times since May 14, 2021. The stock moves an average of ±9.05% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +14.46% (Aug 07, 2023) and its largest decline was -40.48% (May 09, 2025). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How PLX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±9.05%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☀ PRE	+8.04%	open_in_new
May 13, 2026	☀ PRE	+2.37%	open_in_new
Mar 18, 2026	☀ PRE	-20.79%	open_in_new
Nov 13, 2025	☀ PRE	-9.81%	open_in_new
Aug 14, 2025	☀ PRE	-5.59%	open_in_new
May 09, 2025	☀ PRE	-40.48%	open_in_new
Mar 17, 2025	☀ PRE	+9.37%	open_in_new
Nov 14, 2024	☀ PRE	+13.71%	open_in_new
Aug 14, 2024	☀ PRE	-10.58%	open_in_new
May 10, 2024	☀ PRE	-12%	open_in_new
Mar 14, 2024	☀ PRE	-9.87%	open_in_new
Nov 06, 2023	☀ PRE	-18.38%	open_in_new
Aug 07, 2023	☀ PRE	+14.46%	open_in_new
May 18, 2023	☀ PRE	-9.32%	open_in_new
Feb 27, 2023	☀ PRE	+2.75%	open_in_new
Nov 14, 2022	☀ PRE	+1.9%	open_in_new
Aug 15, 2022	☀ PRE	+0.81%	open_in_new
May 16, 2022	☀ PRE	+0.94%	open_in_new
Mar 31, 2022	☀ PRE	+0.95%	open_in_new
Nov 15, 2021	☀ PRE	+0.88%	open_in_new
Aug 16, 2021	☀ PRE	-1.49%	open_in_new
May 14, 2021	☀ PRE	-4.53%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.05%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →

Funds holding

$16921198

Total value held

Buying

13 added · 3 reduced

Blackrock, Inc.

$9428694 +11.88%

State Street Corp

$2291746 +1.11%

Northern Trust Corp

$2149053 +4.17%

Goldman Sachs Group Inc

$1108899 +89.35%

Bank Of New York Mellon Corp

$542871 +6.24%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
10-Q	20260812	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov

Frequently asked about PLX earnings

When does Protalix BioTherapeutics, Inc. report earnings next? expand_more

Protalix BioTherapeutics, Inc. (PLX)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PLX stock move after earnings? expand_more

Over 22 reports, PLX has moved an average of ±9.05% the session after earnings, closing higher 50.0% of the time.

What was PLX's biggest post-earnings move? expand_more

PLX's largest post-earnings gain on record was +14.46% on Aug 07, 2023, and its largest decline was -40.48% on May 09, 2025.

Where can I find Protalix BioTherapeutics, Inc.'s SEC filings? expand_more

All of Protalix BioTherapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.